Quantcast

Needle-Free Delivery: Technology And Market 2013-2023

September 30, 2013

Reportbuyer.com just published a new market research report: Needle-Free Delivery: Technology And Market 2013-2023.

(PRWEB) September 30, 2013

Report Details

Needle-free delivery – discover technological and commercial prospects

What does the future hold for the needle-free delivery market? Visiongain's report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for the overall needle-free injection technology market. There is urgent need for needle-free delivery methods, driven by needle/syringe safety concerns and their lack of suitability for mass immunisation programmes. Our study lets you assess sales data for the global needle-free delivery market, its submarkets and leading national markets. You also find that industry's most promising and lucrative segments, helping your research and analyses.

Forecasts and other analyses to help you stay ahead in knowledge

In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. You see qualitative analysis (SWOT analysis), business news, outlooks and developmental trends. You gain 94 tables and figures and 2 interviews with experts in the field.

Is finding commercial details a challenge? With our report you can get ahead in knowledge, benefiting your research, analyses and decisions. Discover areas that will prosper, reducing the risk of your being left behind.

You discover industry dynamics and growth potentials – the following sections show what you find in our new report.

Discover prospects for the world market and submarkets

Along with revenue prediction for the overall world market, you see forecasts to 2023 for these submarkets:

•Jet Injectors market

•Competing needle-free technology market

The competing needle-free technology market is further segmented into:

•Novel needle technology (includes microneedles and pen needles)

•Inhaler technology

•Patch technology.

With our investigation you gain business information with individual sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints. See what's likely to achieve the most success.

You can gain competitive advantages by understanding the trends, opportunities and challenges facing the needle-free delivery market.

Our work also breaks the main world forecast into leading geographical markets.

What prospects for leading regions and countries?

Developments worldwide will influence the market from 2013, especially the expansion of healthcare in emerging countries. There are many opportunities for companies developing needle-free technologies. See prospects for the industry.

You get individual forecasts to 2023 for nine national markets, finding overall revenues:

•US

•Japan

•Germany, France, UK, Italy and Spain

•India and China.

Discover progress and outlooks. You assess the industry's future – hear about developments and find their significance. Our work explains, exploring many issues.

What issues will affect the needle-free delivery market?

Our report discusses issues and events affecting that industry and market from 2013, looking ahead:

•Growing demand for minimally invasive delivery methods

•Mass immunisation programmes

•Booming global vaccine market

•Opportunities in the needle-free delivery market.

Also, you find coverage of these aspects:

•Regulation of needle-free delivery devices

•Needle-free devices in development

•Challenges faced by jet injectors and microneedle technology.

See what the future holds. You investigate technological, commercial, economic and political matters, with emphasis on the competitive landscape and business outlooks.

Leading companies and 2017 market value

What will happen next? We predict the overall world market for needle-free delivery devices will reach $2.4bn in 2017, and expand further to 2023.

Our study shows you what technologies, products and organisations hold greatest potential. We explore these leading companies:

•Antares Pharma

•Zogenix

•Bioject Medical Technologies

•3M.

From 2013 to 2023, many opportunities will arise. Our work shows you the technological and commercial possibilities, helping you stay ahead.

Seven ways Needle-Free Delivery: Technology and Market 2013-2023 helps

To sum up, our investigation gives you the following knowledge:

•Revenues to 2023 for the overall world market and 5 submarkets – you discover that industry's prospects

•Forecasting to 2023 for the US, Japan, Germany, France, UK, Spain, Italy, India and China – you see leading national sales potentials

•Assessments of 4 leading companies – you find activities, products, capabilities and outlooks

•Opinions on the sector – you read our industry interviews with experts

•Understanding of competition and opportunities – you see what affects that industry, learning what shapes its future

•Analysis of what stimulates and restrains the industry and market – you assess challenges and strengths

•Prospects for established firms and those seeking to enter the sector – you explore needs, practices and outlooks for success.

Benefit from our analyses, gaining information found nowhere else

That work gives independent analysis from our primary and secondary research. You receive business intelligence found only in our study, seeing where prospects are lucrative and growth is likely.

With our report you are less likely to fall behind in knowledge or miss opportunity. See how our work could benefit your research, analyses and decisions, saving you time and getting you recognition for commercial insight.

Discover technological and commercial prospects from 2013 by ordering now

Visiongain's study is for everyone needing analysis of the industry and market for needle-free delivery technology. You find data, trends and predictions. Please ask for our report now.

Visiongain is a trading partner with the US Federal Government

CCR Ref number: KD4R6

Table of Contents

1.Executive Summary

1.1 Sector Highlights

1.2 Aim, Scope and Format of This Report

1.3 Chapter Outline

1.4 Research and Analysis Methods

1.5 Glossary of Terms Relating to the Report

2. Introduction to Needle-Free Delivery of Drug/Vaccines

2.1 What is Needle-Free Technology?

2.1.1 History of Needle-Free Injections (NFI)

2.2 Why the Need For Needle-Free Delivery Technology?

2.2.1 Needle Stick Injury

2.2.1.1 Blood-Borne Pathogens and Needle Stick Injury

2.2.1.2 Accidental Needle Stick Injury: A Serious Healthcare Problem

2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial

2.3.1 Pain Management

2.3.2 Vaccine Delivery

2.3.2.1 The Global Vaccine Market, 2012-2023

2.3.2.2 Needle-Free Vaccine Delivery

2.3.2.3 Mass Immunisation

2.3.3 Insulin Delivery For Diabetics

2.3.4 Paediatric Injections

2.3.5 Other Uses For Needle-Free Injection Technology

2.4 Advantages and Disadvantages of Needle-Free Injections

2.5 The Needle-Free Delivery Market

2.5.1 Jet Injectors

2.5.1.1 Strengths and Weaknesses of Jet Injectors

2.5.2 Competing Technologies

2.5.2.1 Novel Needle Technology

2.5.2.1.1 Pen Needles

2.5.2.1.2 Microneedles

2.5.2.1.3 Hollow Microneedles

2.5.2.1.4 Solid Coated Microneedles

2.5.2.1.5 Solid Biodegradable Microneedles

2.5.2.1.6 Solid Uncoated Microneedles

2.5.2.1.7 Selection of Microneedles

2.5.2.2 Inhaler Technology

2.5.2.3 Patch Technology

2.6 Regulation of the Needle-Free Delivery Market

2.6.1 The US Regulation System

2.6.2 The European Regulation System

2.6.2.1 Post Marketing Surveillance in the EU

3. The Needle-Free Delivery Technology Market, 2013-2023

3.1 The Needle-Free Delivery Technology Market: Overview

3.2 The Needle-Free Delivery Technology Market by Segment, 2011

3.2.1 The Needle-Free Delivery Technology Market: Breakdown by Segment, 2011

3.3 The Needle-Free Delivery Market Forecast, 2012-2023

3.4 Needle-Free Delivery Technology: Market Trends, 2013-2023

3.5 Drivers and Restraints in the Needle-Free Delivery Market, 2013-2023

3.5.1 Drivers

3.5.1.1 Growing Demand For Minimally Invasive Delivery Methods

3.5.1.2 Patent Expiry Will Increase Competition

3.5.1.3 Booming Global Vaccines Market

3.5.1.4 Growth in Biologics Market

3.5.2 Restraints

3.5.2.1 Expensive Technology with Currently Limited Market Penetration

3.5.2.2 Limited Clinical Data May Restrain the Market

3.5.2.3 Regulatory Bodies May Restrain Market Growth

4. The Jet Injectors Technology Market, 2013-2023

4.1 The Jet Injectors Market: Overview

4.2 The Jet Injectors Market by Segment, 2011

4.3 The Jet Injectors Market Forecast by Leading Segments, 2012-2017

4.4 The Jet Injectors Market Forecast by Leading Segments, 2017-2023

4.5 Leading Devices in the Jet Injectors Market, 2013

4.5.1 Biojector 2000 (Bioject Medical Technologies)

4.5.2 SUMAVEL DosePro (Zogenix)

4.5.3 E-Jet 100 (Eurojet Medical)

4.5.4 STRATIS (Pharmajet)

4.5.5 ZetaJet (Bioject Medical Technologies)

4.5.6 LectraJet (D'Antonio Consultants International)

4.5.7 Med-Jet (Medical International Technologies)

4.5.8 Vision (Antares Pharma)

4.5.9 Glide System (Glide Pharmaceutical Technologies)

4.5.10 AdvantaJet (Activa Brand Products)

4.5.11 J-Tip (National Medical Products)

4.5.12 SQ-Pen (Diabetes Management International)

4.5.13 Vitajet (Bioject Medical Technologies)

4.5.14 Penjet (Penjet Corporation)

4.6 Jet Injectors Development Pipeline, 2013

4.6.1 Zeneo (Crossject Medical Technologies)

4.6.2 Jupiter Jet (Bioject Medical Technologies)

4.6.3 Iject (Bioject Medical Technologies)

4.6.4 Iject R (Bioject Medical Technologies)

4.6.5 Relday (Zogenix)

4.7 Concluding Remarks

5. Competing Needle-Free Technology Market, 2013-2023

5.1 Competing Needle-Free Technologies: Overview

5.2 Competing Needle-Free Technology Market, 2011

5.3 Competing Needle-Free Technologies Market Forecast by Leading Segments, 2012-2017

5.4 Competing Needle-Free Technologies Market Forecast by Leading Segments, 2017-2023

5.5 Novel Needle Technology, 2011

5.5.1 Novel Needle Technology Market Forecast, 2012-2023

5.5.2 Leading Products in the Microneedle Technology Market, 2013

5.6 Inhaler Technology Market, 2011

5.6.1 Inhaler Technology Market Forecast, 2012-2023

5.6.2 Inhalers in the Asthma Market, 2013

5.6.3 Inhalers in the Insulin Market, 2013

5.6.4 Inhalers in the Vaccine Market, 2013

5.7 Patch Technology Market, 2011

5.7.1 Patch Technology Market Forecast, 2012-2023

5.7.2 Drug Patches in the Market, 2013

5.7.3 Patches For Vaccine Delivery, 2013

5.8 Competing Needle-Free Technology Development Pipeline, 2013

5.8.1 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)

5.8.2 Microneedle Patch For the Polio Vaccine (Georgia Tech's School of Chemical and Biomolecular Engineering)

5.8.3 AdminPen (nanoBioSciences)

5.8.4 PKA SoftTouch (PKA SoftTouch Corp)

5.8.5 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)

5.8.6 Inhalable Measles Vaccine (Johns Hopkins Bloomberg School of Public Health and the University of Colorado)

5.8.7 Nanotechnology Implant (University of California, San Francisco)

5.8.8 DrugMAT (TheraJect)

5.8.9 MicroCor (Corium International)

5.9 Concluding Remarks

6. Leading National Needle-Free Delivery Markets, 2013-2023

6.1 Regional Breakdown of the Needle-Free Delivery Market, 2011

6.2 Needle-Free Delivery Market: Regional Forecast, 2012-2023

6.3 The US Market

6.4 The European Market

6.4.1 The German Market

6.4.2 The French Market

6.4.3 The Italian Market

6.4.4 The Spanish Market

6.4.5 The UK Market

6.5 The Japanese Market

6.6 The Chinese Market

6.7 The Indian Market

7. Leading Companies in the Needle-Free Delivery Market

7.1 Antares Pharma

7.1.1 Sales and Performance Analysis, 2012

7.1.2 Product Sales, 2012

7.1.3 Technology of Antares Pharma

7.1.3.1 Pressure Assisted Injection Devices

7.1.3.2 Transdermal Gel System

7.1.4 Marketed Products, 2013

7.1.5 Pipeline Products, 2013

7.2 Zogenix

7.2.1 Sales and Performance Analysis, 2011

7.2.2 DosePro – Core Technology of Zogenix

7.2.3 Marketed Products, 2013

7.2.4 Pipeline Products, 2013

7.3 Bioject Medical Technologies

7.3.1 Sales and Performance Analysis

7.3.2 Core Technology of Bioject

7.3.3 Marketed Products, 2013

7.4 3M

7.4.1 Sales and Performance Analysis, 2011

7.4.2 3M Drug Delivery Systems

8. Qualitative Analysis of the Needle-Free Delivery Market, 2013-2023

8.1 SWOT Analysis of the Needle-Free Delivery Market, 2013-2023

8.2 Strengths

8.2.1 Needle-Free Injections Offer a Less Painful Alternative

8.2.2 No Specialist Training Required For Drug/Vaccine Delivery

8.2.3 Reduction in Transport Costs

8.3 Weaknesses

8.3.1 Current Technology is Very Expensive

8.3.2 The Manufacturing Process is Slow and Inefficient

8.3.3 Many Drugs Need Reformulating Before Use with Needle-Free Injection Technology

8.4 Opportunities

8.4.1 Emerging Economies Offer Significant Growth Opportunities

8.4.2 Mass Immunisation Programmes Across the Globe

8.4.3 DNA and Other Vaccines Offer Opportunity For Growth

8.5 Threats

8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce

8.5.2 Limited Clinical Data Threatens to Stifle Innovation and Restrain the Market

8.5.3 Medical Device Excise Tax

9. Expert Opinions

9.1 Interview with John Turanin, Vice President and General Manager, Zogenix

9.1.1 The Needle-Free Injection Technology Market

9.1.2 Impact of Needle-Free Jet Injectors on Drug and Vaccine Delivery

9.1.3 On SUMAVEL DosePro, a Leading Product in the Market

9.1.4 Factors Limiting the Growth of Jet Injectors

9.2 Interview with Dr Faz Chowdhury, Chief Executive Officer of Nemaura Pharma

9.2.1 Challenges Limiting the Growth of Transdermal Delivery

9.2.2 Growth of Microneedle Patch Technology

9.2.3 Thoughts on Other Needle-Free Technologies in the Market

10. Conclusions

10.1 The Needle-Free Delivery Market, 2013-2023

10.2 Gas/Air Powered Jet Injectors Will Drive the Jet Injectors Market

10.3 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market

10.4 Concluding Remarks

List of Tables

Table 2.1 The Global Vaccine Market Forecast ($bn), 2011-2023

Table 2.2 Rationale For Needle-Free Vaccine Delivery

Table 2.3 Key Examples of Needle-Free Vaccine Delivery Systems, 2013

Table 2.4 Key Examples of Needle-Free Insulin Delivery Systems For Diabetics, 2013

Table 2.5 Advantages and Disadvantages of Needle-Free Injections

Table 2.6 Classification of Jet Injectors by Method of Propulsion

Table 2.7 Strengths and Weaknesses of Jet Injectors

Table 2.8 Pen Needle Technology by Needle Length

Table 2.9 FDA Guidance on Regulation of Needle-Free Injectors, 2013

Table 3.1 The Needle-Free Delivery Market: Sales ($m) and Market Shares (%) by Segment, 2011

Table 3.2 The Needle-Free Delivery Market Forecast ($m) by Segment, 2011-2023

Table 3.3 Drivers and Restraints in the Needle-Free Delivery Market, 2013-2023

Table 3.4 Patent Expiries For Leading Drugs, 2011-2013

Table 3.5 The Global Vaccine Market Forecast ($bn), 2011-2023

Table 4.1 The Jet Injectors Market: Sales ($m) and Market Shares (%) by Segment, 2011

Table 4.2 The Jet Injectors Market Forecast ($m), 2011-2017

Table 4.3 The Jet Injector Market Forecast ($m), 2017-2023

Table 4.4 Leading Devices in the Jet Injectors Market, 2013

Table 4.5 The Jet Injectors Development Pipeline, 2013

Table 4.6 Crossject: Zeneo Development Pipeline, 2013

Table 5.1 Competing Needle-Free Technology Market: Sales ($m) and Market Shares (%) by Segment, 2011

Table 5.2 Competing Needle-Free Technology Market Forecast ($m) by Segment, 2011-2017

Table 5.3 Competing Needle-Free Technology Market Forecast ($m) by Segment, 2017-2023

Table 5.4 Novel Needle Technology Market Forecast ($m), 2011-2023

Table 5.5 Leading products in the Novel Needle Technology Market, 2013

Table 5.6 Inhaler Technology Market Forecast ($m), 2011-2023

Table 5.7 Leading Inhalers in the Asthma Market, 2013

Table 5.8 Insulin Inhalers Previously Developed and Availability in 2013

Table 5.9 Vaccine Inhalers Currently Under Development, 2013

Table 5.10 Patch Technology Market Forecast ($m), 2011-2023

Table 5.11 Drug Patches in the Market, 2013

Table 5.12 Competing Needle-Free Technology Development Pipeline, 2013

Table 6.1 Leading National Needle-Free Delivery Markets: Sales ($m) and Market Shares (%), 2011

Table 6.2 Needle-Free Delivery Market Forecast ($m) by Leading National Markets, 2011-2017

Table 6.3 Needle-Free Delivery Market Forecast ($m) by Leading National Markets, 2017-2023

Table 6.4 The Leading European Needle-Free Delivery National Markets: Sales ($m) and Market Shares (%), 2011

Table 6.5 The European Needle-Free Delivery Market Forecast ($m) by Leading Countries, 2011-2017

Table 6.6 The European Needle-Free Delivery Market Forecast ($m) by Leading Countries, 2017-2023

Table 7.1 Antares Pharma: Revenue ($m) and Revenue Shares (%) by Business, 2012

Table 7.2 Antares Pharma: Revenue ($m) and Revenue Shares (%), by Product Type, 2012

Table 7.3 Antares Pharma: Products Under Development, 2013

Table 7.4 Zogenix: Revenue ($m) and Revenue Shares (%), by Business, 2011

Table 7.5 Bioject: Revenue ($m) and Revenue Shares (%), by Product Line, 2011

Table 7.6 3M: Net Sales ($bn) and Net Sales Shares (%) by Business Segments, 2011

Table 8.1 SWOT Analysis of the Needle-Free Delivery Market, 2013-2023

Table 8.2 Average Price For Needle-Free Drug/Vaccine Delivery Technology, 2013

Table 10.1 Leading Segments of the Needle-Free Delivery Market ($m), 2011, 2013, 2017 & 2023

List of Figures

Figure 2.1 The Global Vaccine Market Forecast ($bn), 2011-2023

Figure 3.1 The Needle-Free Delivery Market: Sales ($m) by Segment, 2011

Figure 3.2 The Needle-Free Delivery Market: Market Shares (%) by Segment, 2011

Figure 3.3 The Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 3.4 The Needle-Free Delivery Market Forecast ($m) by Segment, 2011-2023

Figure 3.5 The Global Vaccine Market Forecast ($bn), 2011-2023

Figure 4.1 The Jet Injectors Market: Sales ($m) by Segment, 2011

Figure 4.2 The Jet Injectors Market: Market Shares (%) by Segment, 2011

Figure 4.3 The Jet Injectors Market Forecast ($m), 2011-2017

Figure 4.4 The Jet Injectors Market Forecast ($m) by Segment, 2011-2017

Figure 4.5 The Jet Injectors Market Forecast ($m), 2017-2023

Figure 4.6 The Jet Injectors Market Forecast ($m) by Segment, 2017-2023

Figure 5.1 Competing Needle-Free Technology Market: Sales ($m) by Segment, 2011

Figure 5.2 Competing Needle-Free Technology Market: Market Shares (%) by Segment, 2011

Figure 5.3 Competing Needle-Free Technology Market Forecast ($m), 2011-2017

Figure 5.4 Competing Needle-Free Technology Market Forecast ($m) by Segment, 2011-2017

Figure 5.5 Competing Needle-Free Technology Market Forecast ($m), 2017-2023

Figure 5.6 Competing Needle-Free Technology Market Forecast ($m) by Segment, 2017-2023

Figure 5.7 Novel Needle Technology Market Forecast ($m), 2011-2023

Figure 5.8 Inhaler Technology Market Forecast ($m), 2011-2023

Figure 5.9 Patch Technology Market Forecast ($m), 2011-2023

Figure 6.1 Needle-Free Delivery Market: Sales ($m) in Leading National Markets, 2011

Figure 6.2 Needle-Free Delivery Market: Market Shares (%) in Leading National Markets, 2011

Figure 6.3 US Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 6.4 The European Needle-Free Delivery Markets: Sales ($m) in Leading National Markets, 2011

Figure 6.5 The European Needle-Free Delivery Markets: Market Shares (%) in Leading National Markets, 2011

Figure 6.6 The European Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 6.7 The German Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 6.8 The French Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 6.9 The Italian Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 6.10 The Spanish Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 6.11 The UK Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 6.12 The Japanese Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 6.13 The Chinese Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 6.14 The Indian Needle-Free Delivery Market Forecast ($m), 2011-2023

Figure 7.1 Antares Pharma: Revenue ($m) by Business, 2012

Figure 7.2 Antares Pharma: Revenue Shares (%) by Business, 2012

Figure 7.3 Antares Pharma: Revenue ($m) by Product Type, 2011

Figure 7.4 Antares Pharma: Revenue Shares (%) by Product Type, 2011

Figure 7.5 Zogenix: Revenue ($m) by Business, 2011

Figure 7.6 Zogenix: Revenue Shares (%) by Business, 2011

Figure 7.7 Bioject: Revenue ($m) by Product Line, 2011

Figure 7.8 Bioject: Revenue Shares (%) by Product Line, 2011

Figure 7.9 3M: Net Sales ($bn) by Business Segments, 2011

Figure 8.1 The Transport Process For a Vaccine

Figure 10.1 Global Needle-Free Delivery Market Sales ($m) in 2011, 2013, 2017 & 2023

Figure 10.2 Global Needle-Free Delivery Market Sales ($m) by Segments in 2011, 2013, 2017 & 2023

Companies Listed

3M

Actavis

Activa Brand Products

Acushot

Alkermes

Altea Development Corporation

Alza

Anesiva

Antares Pharma

Astellas Pharma

Astra Zeneca

Australian Institute for Bioengineering and Nanotechnology

Becton Dickinson

Berlex Labs

Bespak

Bioject Medical Technologies

Boehringer Ingelheim

Cambridge Consultants

Center for Devices and Radiological Health (CDRH)

Corium International

Crossject Medical Technologies

CSL Behring

CSL Biotherapies

D'Antonio Consultants International

Daewoong Pharmaceuticals

Debiotech

Diabetes Management International

Durect

Echo Therapeutics

Elan Corporation

Eli Lily &Co

Eloquest Healthcare

EMD Serono

Emory University

Eurojet Medical

Ferndale Pharma Group

Ferring Pharmaceuticals

Food and Drug Administration (FDA) US

Generex

Georgia Tech's School of Chemical and Biomolecular Engineering

GlaxoSmithKline (GSK)

Glide Pharmaceutical Technologies

Gwangju Institute of Science and Technology

Harvard University

Indian Institute of Science, Bangalore

Intercell

Janssen Pharmaceuticals

JCR Pharmaceuticals

John Hopkins Bloomberg School of Public Health

Key Pharmaceuticals

Lederle Labs

Leiden University

LigoCyte Pharmaceuticals

Mannkind

Medical International Technologies

MedImmune

Merck &Co

NanoBiosciences

Nanopass Technologies

National Health Service (NHS)

National Institute of Health (NIH)

National Medical Products

Nektar Therapeutics

Nemaura Pharma

Novartis

Novo Nordisk

NuPathe

Nycomed

Ortho-McNiel

Owen Mumford

Parke-Davis

PenJet Corporation

Pfizer

Pharmacia and Upjohn Company

Pharmajet

PKA SoftTouch Corp

PowderJect Pharmaceuticals

Procter and Gamble

Sanofi

Sanofi-Pasteur

Schering

Schwarz Pharma

Serum Institute of India

Shreya Life Sciences

Stat Medical Devices

State Food and Drug Administration (SFDA) China

Teva Pharmaceuticals

TheraJect

Theratechnologies

Trinity Chiesi

UCB

University Erlangen-Nurnberg

University of California

University of Colorado

University of Queensland

Watson Pharmaceuticals

World Health Organization (WHO)

Zogenix

Zosano Pharma

Zydus Cadila

Read the full report:

Needle-Free Delivery: Technology And Market 2013-2023

http://www.reportbuyer.com/pharma_healthcare/diagnostics/needle_free_delivery_technology_market_2013_2023.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11177482.htm


Source: prweb



comments powered by Disqus